Skip to content

AxoGen

US · AXGN #2714 by market cap Listed 1970
55.75 -0.60 -1.06%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About AxoGen

Axogen, Inc. engages in the development and marketing of surgical solutions for peripheral nerve regeneration and repair. It provides products and educational resources to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Avive Soft Tissue Membrane, AcroVal Neurosensory and Motor Testing System, and AxoTouch Two-Point Discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Founded
1977
CEO
Mr. Michael J. Dale
Employees
622
Headquarters
Alachua, Florida, United States of America
Fiscal year end
12-31
Website
axogeninc.com

Company profile

Exchange
US
Symbol
AXGN
Market-cap rank
#2714
Listing date
1970-01-01
Market cap
3.33B
Float cap
3.04B
Shares out
59.73M
Float shares
54.61M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

AxoGen discussion 0 comments

Add a comment